Blood Pressure Control and Improved Cardiovascular Outcomes in the International Verapamil SR-Trandolapril Study

No abstract is available for this paper.

• Publication year

  2007

• Venue

  HYPERTENSION

• Publication date

  2007-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.107.090290PMID 17606861
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis

  2007cited by this paper
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

  2007cited by this paper
• Predictors of adverse outcome among patients with hypertension and coronary artery disease.

  2006cited by this paper
• Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial

  2006cited by this paper
• Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous?

  2006cited by this paper
• Effects of Different Blood Pressure-Lowering Regimens on Major Cardiovascular Events in Individuals With and Without Diabetes Mellitus: Results of Prospectively Designed Overviews of Randomized Trials

  2006cited by this paper
• Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial.

  2005cited by this paper
• Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials

  2005cited by this paper
• Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.

  2005cited by this paper
• Outcomes in Hypertensive Black and Nonblack Patients Treated With Chlorthalidone, Amlodipine, and Lisinopril

  2005cited by this paper
• Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.

  2005cited by this paper
• Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial.

  2004cited by this paper
• Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

  2004cited by this paper
• Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

  2004cited by this paper
• Clinical Outcomes in the Diabetes Cohort of the International Verapamil SR-Trandolapril Study

  2004cited by this paper
• A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

  2003cited by this paper
• Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

  2003cited by this paper
• Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

  2003cited by this paper
• 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

  2003cited by this paper
• Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

  2002cited by this paper
• Prognostic value of systolic and diastolic blood pressure in treated hypertensive men.

  2002cited by this paper
• Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

  2002cited by this paper
• Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39

  1998cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension.

  1998cited by this paper
• The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

  1997cited by this paper
• Mortality in patients of the Glasgow Blood Pressure Clinic.

  1986cited by this paper
• Original Papers

  1986cited by this paper

• The Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025)

  2026cites this paper
• Choice of Reference Blood Pressure in the 2023 Guidelines of the European Society of Hypertension

  2025cites this paper
• Long-Term Time in Target Range for Systolic Blood Pressure Since Childhood and Midlife Arterial Stiffness

  2025cites this paper
• Blood Pressure Time in Target Range Within 24 Hours and Cardiovascular Diseases and Mortality: Perspectives From a Real-World Cohort Study.

  2025cites this paper
• Development and validation of 10‐year risk prediction models of cardiovascular disease in Chinese type 2 diabetes mellitus patients in primary care using interpretable machine learning‐based methods

  2024cites this paper
• Time in target range for systolic blood pressure and glucose with cardiovascular disease and all-cause mortality risks

  2024cites this paper
• Impact of seasonal blood pressure changes on visit-to-visit blood pressure variability and related cardiovascular outcomes

  2024cites this paper
• Comparison between visit-to-visit office and 24-h blood pressure variability in treated hypertensive patients

  2023cites this paper
• Drug Discovery for Periodontitis Treatment Based on Big Data Mining, Systems Biology, and Deep Learning Methods

  2023cites this paper
• 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH).

  2023cites this paper
• Perspectives on improving blood pressure control to reduce the clinical and economic burden of hypertension

  2023cites this paper
• Hypertensive Heart Failure

  2023cites this paper
• Longer time in blood pressure target range improves cardiovascular outcomes among patients with Type 2 diabetes: A Secondary Analysis of a Randomized Clinical Trial.

  2023cites this paper
• Middle-Aged and Older Patients With Left Ventricular Hypertrophy: Higher Mortality With Drug Treated Systolic Blood Pressure Below 130 mm Hg

  2023cites this paper
• Pharmacological Management of Primary Arterial Hypertension: A Century of Expert Opinions in Cecil Textbook of Medicine

  2022cites this paper
• Association of AGTR1 A1166C and CYP2C9∗3 Gene Polymorphisms with the Antihypertensive Effect of Valsartan

  2022cites this paper
• Prevalence, risk factors, and cardiovascular disease outcomes associated with persistent blood pressure control: The Jackson Heart Study

  2022cites this paper
• Blood Pressure Fluctuation During Hospitalization and Clinical Outcomes Within 3 Months After Ischemic Stroke

  2022cites this paper
• Blood pressure control measures and cardiovascular outcomes: a prospective hypertensive cohort

  2022cites this paper
• Prognostic Value of Time in Blood Pressure Target Range Among Patients With Heart Failure.

  2022cites this paper
• Target Blood Pressure and Combination Therapy: Focus on Angiotensin Receptor Blockers Combination with Either Calcium Channel Blockers or Beta Blockers.

  2022cites this paper
• Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Range.

  2022cites this paper
• PROGNOSTIC SIGNIFICANCE AND LIMITATION OF VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY IN PATIENTS WITH REDUCED EJECTION FRACTION: A MINI-REVIEW.

  2022cites this paper
• Wellens syndrome as an independent predictor of in-hospital cardiovascular complications

  2022cites this paper
• Does blood pressure variability affect hypertension development in pre-hypertensive patients?

  2021cites this paper
• Effect of a Physician/Pharmacist Collaborative Care Model on Time in Target Range for Systolic Blood Pressure: Post Hoc Analysis of the CAPTION Trial

  2021cites this paper
• Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus and hypertension

  2021cites this paper
• Longitudinal Blood Pressure Patterns and Chronic Kidney Disease Progression: An Evolving Paradigm.

  2021cites this paper
• Blood pressure target in patients with hypertension and type-2 diabetes older than 65 years. Is <130/80 mmHg the right target or an excessive objective preventing from achieving the clinical goals we are aiming at?

  2021cites this paper
• Sustained SBP control and long-term nursing home admission among Medicare beneficiaries

  2021cites this paper
• Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus compared to all middle-aged and elderly hypertensive study patients with high cardiovascular risk

  2021cites this paper
• Impact of carboxylesterase 1 genetic polymorphism on trandolapril activation in human liver and the pharmacokinetics and pharmacodynamics in healthy volunteers

  2021cites this paper
• Guide de Pratique Clinique. Prise en charge de l’hypertension artérielle chez l’adulte en Tunisie

  2021cites this paper
• Antihypertensive constituents in Sanoshashinto

  2020cites this paper
• Antihypertensive constituents in Sanoshashinto

  2020cites this paper
• Visit-to-visit blood pressure variability in patients with type 2 diabetes with and without previous history of cardiovascular disease.

  2020cites this paper
• Analysis of Adherence to Antihypertensive Drugs in Chinese Patients with Hypertension: A Retrospective Analysis Using the China Health Insurance Association Database

  2020cites this paper
• Analysis of Adherence to Antihypertensive Drugs in Chinese Patients with Hypertension: A Retrospective Analysis Using the China Health Insurance Association Database

  2020cites this paper
• Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials.

  2020cites this paper
• Impact of Arterial Stiffness on All-Cause Mortality in Patients Hospitalized With COVID-19 in Spain

  2020cites this paper
• Cardiovascular Risk Factors: It's Time to Focus on Variability!

  2020cites this paper
• Comparison of blood pressure variability between losartan and amlodipine in essential hypertension (COMPAS-BPV).

  2020cites this paper
• Beta-blockers in hypertension: overview and meta-analysis of randomized outcome trials.

  2020cites this paper
• Consistency of Blood Pressure Control: a Useful Tool of Hypertension Assessment in a Vulnerable Population

  2019cites this paper
• Risk Factor Variability and Cardiovascular Outcome: JACC Review Topic of the Week.

  2019cites this paper
• Sustained blood pressure control and coronary heart disease, stroke, heart failure, and mortality: An observational analysis of ALLHAT

  2019cites this paper
• Inhibition of angiotensin II-induced cerebrovascular smooth muscle cell proliferation by LRRC8A downregulation through suppressing PI3K/AKT activation

  2019cites this paper
• 2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations

  2019cites this paper
• Guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial

  2019cites this paper
• Adherence in Hypertension.

  2019cites this paper
• Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks

  2018cites this paper
• 2018 ESC/ESH Guidelines for the management of arterial hypertension.

  2018cites this paper
• Differences in visit-to-visit blood pressure variability between normotensive and hypertensive pregnant women

  2018cites this paper
• Prevalence and Determinants of Blood Pressure Control among Hypertensive Patients in Primary Care Centers, Najran, Saudi Arabia

  2018cites this paper
• Acetylshikonin attenuates angiotensin II-induced proliferation and motility of human brain smooth muscle cells by inhibiting Wnt/β-catenin signaling

  2018cites this paper
• prevalence and determinants of blood pressure control among patients with hypertension in primary care settings najran area saudi arabia

  2018cites this paper
• Visit-to-visit SBP variability and cardiovascular disease in a multiethnic primary care setting: 10-year retrospective cohort study

  2017cites this paper
• Arterial Stiffness and Blood Pressure Variability

  2017cites this paper
• Relative and Combined Prognostic Importance of On-Treatment Mean and Visit-to-Visit Blood Pressure Variability in ONTARGET and TRANSCEND Patients

  2017cites this paper
• Short‐term blood pressure variability in acute coronary syndrome

  2017cites this paper
• Treating Visit-to-Visit Blood Pressure Variability to Improve Prognosis: Is Amlodipine the Drug of Choice?

  2017cites this paper
• Blood pressure and cardiovascular outcomes: a closer look.

  2017cites this paper
• Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial.

  2017cites this paper
• Drug adherence in hypertension

  2017cites this paper
• Blood pressure-lowering agents response : a systematic review and genome wide study

  2017cites this paper
• Treatment of hypertension: The ESH/ESC guidelines recommendations.

  2017cites this paper
• Visit-to-Visit Blood Pressure Variability: An Insight Into the Mechanisms.

  2016cites this paper
• [Chronic ischaemic heart disease in the elderly].

  2016cites this paper
• Visit-to-Visit Variability in Blood Pressure Is Related to Late-Life Cognitive Decline

  2016cites this paper
• Clinical Case 2: Patient with Essential Hypertension and Myocardial Infarction

  2016cites this paper
• Prognostic importance of pretreatment and on-treatment blood pressure: Further analysis of the ACTION database and the effect of nifedipine gastrointestinal therapeutic system

  2016influential citation
• [Chronic ischaemic heart disease in the elderly].

  2016cites this paper
• Hypertension and coronary artery disease: epidemiology, physiology, effects of treatment, and recommendations

  2016cites this paper
• Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.

  2016cites this paper
• A Case for Less Intensive Blood Pressure Control: It Matters to Achieve Target Blood Pressure Early and Sustained Below 140/90mmHg.

  2016cites this paper
• High Systolic and Diastolic Blood Pressure Variability Is Correlated with the Occurrence of Peripheral Arterial Disease in the First Decade following a Diagnosis of Type 2 Diabetes Mellitus: A New Biomarker from Old Measurement

  2016cites this paper
• The Impact of Uncontrolled Hypertension on the Cerebrovascular System

  2016cites this paper
• Análisis de la variabilidad tensional en el hipertenso medida por diferentes métodos y su relación con el daño orgánico.

  2016cites this paper
• Grupo de Trabajo para el manejo de la hipertensión arterial de la Sociedad Europea de Hipertensión (ESH) y la Sociedad Europea de Cardiología (ESC)

  2016cites this paper
• Effect of visit-to-visit blood pressure variability on cardiovascular events in patients with coronary artery disease and well-controlled blood pressure.

  2016influential citation
• ESPECIAL Cardiopatía isquémica crónica en el anciano ! , ! !

  2016cites this paper
• Hypertension in Chronic Kidney Disease Part 2: Role of Ambulatory and Home Blood Pressure Monitoring for Assessing Alterations in Blood Pressure Variability and Blood Pressure Profiles

  2016cites this paper
• [Chronic ischaemic heart disease in the elderly].

  2016cites this paper
• Improving cardiovascular protection: focus on a cardiovascular polypill.

  2016cites this paper
• Importance of sustained and “tight” blood pressure control in patients with high cardiovascular risk

  2016cites this paper
• Adherence to Medications in Uncontrolled Hypertension

  2016cites this paper
• Cardiopatía isquémica crónica en el anciano

  2016cites this paper
• Interventions to Improve Medication Adherence in Hypertensive Patients: Systematic Review and Meta-analysis

  2015cites this paper
• Development of an Experimental Model to Study the Relationship Between Day-to-Day Variability in Blood Pressure and Aortic Stiffness

  2015cites this paper
• Visit-to-Visit Variability of Systolic Blood Pressure and Cardiovascular Disease

  2015cites this paper
• Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer

  2015cites this paper
• Is It Daily, Monthly, or Yearly Blood Pressure Variability that Enhances Cardiovascular Risk?

  2015cites this paper
• Within-visit blood pressure variability is associated with prediabetes and diabetes

  2015cites this paper
• Blood pressure variability predicts cardiovascular events independently of traditional cardiovascular risk factors and target organ damage: a LIFE substudy

  2015cites this paper
• 2013 Korean Society of Hypertension guidelines for the management of hypertension: part III-hypertension in special situations

  2015cites this paper
• PGC-1α overexpression suppresses blood pressure elevation in DOCA-salt hypertensive mice

  2015cites this paper
• Luteolin Ameliorates Hypertensive Vascular Remodeling through Inhibiting the Proliferation and Migration of Vascular Smooth Muscle Cells

  2015cites this paper
• Blood Pressure Variability: Assessment, Predictive Value, and Potential as a Therapeutic Target

  2015cites this paper
• Prevalence and Prognostic Impact of Periodontal Disease and Conventional Risk Factors in Patients with Stable Coronary Heart Disease

  2015cites this paper
• The association of arterial hypertension and ischemic heart disease is the main problem in modern cardiology practice

  2015cites this paper